Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Tricuspid Regurgitation Progression and Adverse Outcomes in Different Pacing Modes

NCT06922526 is registered in ClinicalTrials.gov with Haiyan Wang as lead sponsor.

NCT NCT06922526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06922526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Tricuspid Regurgitation Progression and Adverse Outcomes in Different Pacing Modes
Lead sponsor
Haiyan Wang
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2025
Completion date
May 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pacemaker, tricuspid regurgitation